Effect of regorafenib in delaying definitive deterioration in health-related quality of life in patients with advanced cancer of three different tumor types

The objective of this post hoc exploratory analysis was to explore the impact of regorafenib on delaying HRQOL deterioration across three different tumor types.

Saved in:

Bibliographic Details
Main Authors:	Hofheinz, Ralf-Dieter (Author) , Bruix, Jordi (Author) , Demetri, George D. (Author) , Grothey, Axel (Author) , Marian, Marisca (Author) , Bartsch, Jennifer (Author) , Odom, Dawn (Author)
Format:	Article (Journal)
Language:	English
Published:	12 July 2021
In:	Cancer management and research Year: 2021, Volume: 13, Pages: 5523-5533
ISSN:	1179-1322
DOI:	10.2147/CMAR.S305939
Online Access:	Verlag, Volltext: https://doi.org/10.2147/CMAR.S305939 Verlag: https://www.dovepress.com/effect-of-regorafenib-in-delaying-definitive-deterioration-in-health-r-peer-reviewed-fulltext-article-CMAR
Author Notes:	Ralf-Dieter Hofheinz, Jordi Bruix, George D. Demetri, Axel Grothey, Marisca Marian, Jennifer Bartsch, Dawn Odom

Description
Summary:	The objective of this post hoc exploratory analysis was to explore the impact of regorafenib on delaying HRQOL deterioration across three different tumor types.
Item Description:	Gesehen am 17.01.2023
Physical Description:	Online Resource
ISSN:	1179-1322
DOI:	10.2147/CMAR.S305939